It’s as important as ever to know where you can get treatment to mitigate the worst outcomes of COVID-19 if infected. It is also equally important for high-risk individuals to know where to receive pre-exposure prophylaxis.
About COVID-19 Treatment
Treatments are currently being administered to non-hospitalized patients who test positive for COVID-19. These treatments are most effective when administered within 3–5 days of showing symptoms, depending on treatment type.
Pre-exposure prophylaxis is administered to immunocompromised folks who are not infected with COVID-19 as it provides up to six months of protection. Access to treatments is limited and may not be available when requested.
About Map
This map is intended to be used while coordinating treatment with a healthcare provider. Contact your primary care provider as soon as you test positive to discuss your risk and receive a prescription for treatment.
How to use the map
- Zoom in, click, and drag to explore the map.
- Click on the icons located throughout the map to display the information about the resource.
- If an arrow appears at the top of the location pop-up, click through to see all treatments offered.
- Click the buttons in the upper right corner for the legend or to share a link to this map with others.
- Click the buttons on the upper left side to use helpful tools.
Frequently asked questions
What treatments are available?
Bebtelovimab is a monoclonal antibody that neutralizes the SARS-CoV-2 virus. It is given as an IV drip.
Evusheld is a long-acting monoclonal antibody injection for pre-exposure prophylaxis in uninfected and unexposed individuals that are moderately to severely immunocompromised, or individuals that are not recommended to receive a COVID-19 vaccine due to history of severe adverse reactions.
Molnupiravir and Paxlovid are oral antiviral medications prescribed to be taken daily for five days. Both treatments stop the SARS-CoV-2 virus from replicating. Molnupiravir and Paxlovid are to be taken within five and three days of symptom onset, respectively.
Renal Paxlovid is a form of Paxlovid that is formulated to be safer for individuals with kidney problems.
Evusheld, Molnupiravir, and Paxlovid all require a prescription. Contact your primary care provider as soon as you test positive to discuss your risk and receive a prescription.
COVID-19 clinical trials displayed in this map are subject to change as new clinical trials become available and if clinical trials are no longer enrolling volunteers because they receive enough participants.
Where can I receive treatments prescription?
Retail Pharmacies are able to fill a Molnupiravir, Paxlovid, or Renal Paxlovid prescription written by your provider. Different locations may not be equipped to prescribe these treatments. Have your provider contact your preferred local pharmacy to fill your prescription.
Veterans Affairs sites serve those who have or currently serve in the active military, naval, or air service, and qualify for VA health coverage, and their dependents.
IHS, tribal, and urban health care facilities serve enrolled members of federally recognized tribes, or a qualified descendant of an enrolled person. Certain IHS-contracted facilities may require residency with their service area, and some tribally operated locations may only serve members of their tribe. Before traveling to any IHS/tribal/urban health care facilities, call to ensure that services can be provided to you.
Non-public sites include medical distribution centers, and long-term care, in-patient, and correctional facilities. While these locations are not open for the general public to receive treatment, they have received shipments from the federal government. Knowledge of such shipments is relevant to individuals housed in these facilities and their external support networks.
